Qingdao Vland Biotech INC. (SHA:603739)
China · Delayed Price · Currency is CNY 11.57
+0.04 (0.35%)
Aug 4, 2026, 3:00 PM CST
SHA:603739 Market Cap
SHA:603739 has a market cap or net worth of 2.93 billion as of August 4, 2026. Its market cap has decreased by -21.72% in one year.
Market Cap
2.93B
Enterprise Value
3.25B
Revenue
1.40B
Ranking
n/a
PE Ratio
37.52
Stock Price
11.57
ChartMarket Cap Chart
Since January 16, 2019, SHA:603739's market cap has increased from 2.27B to 2.93B, an increase of 29.03%. That is a compound annual growth rate of 3.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 2.93B | -18.23% |
| Dec 31, 2025 | 3.58B | 18.02% |
| Dec 31, 2024 | 3.03B | -21.22% |
| Dec 29, 2023 | 3.85B | 13.69% |
| Dec 30, 2022 | 3.39B | -27.76% |
| Dec 31, 2021 | 4.69B | 34.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hinova Pharmaceuticals | 3.24B |
| Shanghai Serum Bio-Technology | 3.12B |
| Baolingbao Biology | 3.02B |
| Zhejiang Shouxiangu Pharmaceutical | 2.94B |
| Guanhao Biotech | 2.87B |
| Guangdong VTR Bio-Tech | 2.75B |
| Beijing Kawin Technology Share-Holding | 2.66B |
| Hubei Goto Biopharm Group | 2.59B |